Literature DB >> 5315678

Treatment of adult leukemia with L-asparaginase (NSC-109229).

T Onuma, F Rosner, R N Levy, J Cuttner, J H Moon, R T Silver, J Blom, G Falkson, R Burningham, O Glidewell, J F Holland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5315678

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

1.  Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors:  Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

2.  Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemias.

Authors:  A Raza; A S Raza; K Kuliczkowski; S C Zhao; H D Preisler
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  High-dose ara-C and etoposide in refractory or relapsing acute leukemia.

Authors:  M Freund; H Link; H Diedrich; S LeBlanc; H J Wilke; H Poliwoda
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia.

Authors:  M Freund; S Giller; F Hinrichs; A Baars; J Meran; A Körfer; H Link; H Poliwoda
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.